China Healthcare Cold Chain Logistics Market

ID: MRFR/HC/43357-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026
China Healthcare Cold Chain Logistics Market Research Report By Mode of Delivery (Last-Mile Delivery, Hubs-to-Distributor), By Product (Vaccines, Biopharmaceuticals, Clinical Trial Materials), By Services (Transportation, Storage, Packaging, Labeling, Others), By End User (Hospitals Clinics, Pharmaceutical, Biopharmaceutical, Biotechnology Companies, Others) and By Temperature Range (Ambient, Refrigerated, Frozen, Cryogenic) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

China Healthcare Cold Chain Logistics Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)4.19%
2024 Market Size$ 329 Million
2025 Market Size$ 344.2 Million
2035 Market Size$ 516.6 Million

Key Players

Sinotrans Limited
China National Pharmaceutical Group
SF Express
YTO Express Group
ZTO Express
JD Logistics
Trends
  • Technological Advancements in Cold Chain Solutions
  • Regulatory Compliance and Standards
  • Growing Demand for Biologics and Vaccines
Opportunities
  • Regulatory Compliance and Standards
  • Expansion of E-commerce in Healthcare
  • Investment in Infrastructure Development
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Application (USD Million)
      1. 4.1.1 Pharmaceuticals
      2. 4.1.2 Biologics
      3. 4.1.3 Vaccines
      4. 4.1.4 Clinical Trials
      5. 4.1.5 Blood and Blood Products
    2. 4.2 Healthcare, BY End Use (USD Million)
      1. 4.2.1 Hospitals
      2. 4.2.2 Pharmacies
      3. 4.2.3 Research Laboratories
      4. 4.2.4 Biotechnology Companies
      5. 4.2.5 Logistics Providers
    3. 4.3 Healthcare, BY Temperature Range (USD Million)
      1. 4.3.1 Controlled Room Temperature
      2. 4.3.2 Refrigerated
      3. 4.3.3 Frozen
      4. 4.3.4 Ultra-Low Temperature
      5. 4.3.5 Ambient
    4. 4.4 Healthcare, BY Packaging Type (USD Million)
      1. 4.4.1 Insulated Containers
      2. 4.4.2 Thermal Blankets
      3. 4.4.3 Refrigerated Trucks
      4. 4.4.4 Cryogenic Tanks
      5. 4.4.5 Temperature-Controlled Pallets
    5. 4.5 Healthcare, BY Transport Mode (USD Million)
      1. 4.5.1 Road Transport
      2. 4.5.2 Air Transport
      3. 4.5.3 Rail Transport
      4. 4.5.4 Sea Transport
      5. 4.5.5 Intermodal Transport
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Sinotrans Limited (CN)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 China National Pharmaceutical Group (CN)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 SF Express (CN)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 YTO Express Group (CN)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 ZTO Express (CN)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 JD Logistics (CN)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 DHL Supply Chain (DE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Kuehne + Nagel (CH)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 DB Schenker (DE)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 CHINA MARKET ANALYSIS BY APPLICATION
    3. 6.3 CHINA MARKET ANALYSIS BY END USE
    4. 6.4 CHINA MARKET ANALYSIS BY TEMPERATURE RANGE
    5. 6.5 CHINA MARKET ANALYSIS BY PACKAGING TYPE
    6. 6.6 CHINA MARKET ANALYSIS BY TRANSPORT MODE
    7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF HEALTHCARE
    10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
    13. 6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    14. 6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
    15. 6.15 HEALTHCARE, BY END USE, 2024 (% SHARE)
    16. 6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
    17. 6.17 HEALTHCARE, BY TEMPERATURE RANGE, 2024 (% SHARE)
    18. 6.18 HEALTHCARE, BY TEMPERATURE RANGE, 2024 TO 2035 (USD Million)
    19. 6.19 HEALTHCARE, BY PACKAGING TYPE, 2024 (% SHARE)
    20. 6.20 HEALTHCARE, BY PACKAGING TYPE, 2024 TO 2035 (USD Million)
    21. 6.21 HEALTHCARE, BY TRANSPORT MODE, 2024 (% SHARE)
    22. 6.22 HEALTHCARE, BY TRANSPORT MODE, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million)
      2. 7.2.2 BY END USE, 2026-2035 (USD Million)
      3. 7.2.3 BY TEMPERATURE RANGE, 2026-2035 (USD Million)
      4. 7.2.4 BY PACKAGING TYPE, 2026-2035 (USD Million)
      5. 7.2.5 BY TRANSPORT MODE, 2026-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

China Healthcare Cold Chain Logistics Market Cold Chain Logistics Market Segmentation

China Healthcare Cold Chain Logistics Market By Application (USD Million, 2026-2035)

  • Pharmaceuticals
  • Biologics
  • Vaccines
  • Clinical Trials
  • Blood and Blood Products

China Healthcare Cold Chain Logistics Market By End Use (USD Million, 2026-2035)

  • Hospitals
  • Pharmacies
  • Research Laboratories
  • Biotechnology Companies
  • Logistics Providers

China Healthcare Cold Chain Logistics Market By Temperature Range (USD Million, 2026-2035)

  • Controlled Room Temperature
  • Refrigerated
  • Frozen
  • Ultra-Low Temperature
  • Ambient

China Healthcare Cold Chain Logistics Market By Packaging Type (USD Million, 2026-2035)

  • Insulated Containers
  • Thermal Blankets
  • Refrigerated Trucks
  • Cryogenic Tanks
  • Temperature-Controlled Pallets

China Healthcare Cold Chain Logistics Market By Transport Mode (USD Million, 2026-2035)

  • Road Transport
  • Air Transport
  • Rail Transport
  • Sea Transport
  • Intermodal Transport

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035